RG
Redmile Group’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-449,442
| Closed | -$31.2M | – | 74 |
|
|
2023
Q1 | $31.2M | Buy |
+449,442
| New | +$31.2M | 1.35% | 26 |
|
|
2020
Q1 | – | Sell |
-1,800,800
| Closed | -$116M | – | 70 |
|
|
2019
Q4 | $116M | Sell |
1,800,800
-451,800
| -20% | -$29M | 2.76% | 11 |
|
|
2019
Q3 | $114M | Buy |
2,252,600
+583,200
| +35% | +$29.6M | 3.82% | 7 |
|
|
2019
Q2 | $75.7M | Buy |
1,669,400
+69,700
| +4% | +$3.16M | 2.14% | 13 |
|
|
2019
Q1 | $76.3M | Buy |
1,599,700
+745,000
| +87% | +$35.5M | 2.23% | 16 |
|
|
2018
Q4 | $44.4M | Buy |
+854,700
| New | +$44.4M | 1.79% | 18 |
|
|
2014
Q2 | – | Sell |
-418,500
| Closed | -$21.7M | – | 49 |
|
|
2014
Q1 | $21.7M | Buy |
418,500
+17,630
| +4% | +$916K | 2.6% | 12 |
|
|
2013
Q4 | $21.3M | Buy |
+400,870
| New | +$21.3M | 2.63% | 13 |
|